Venous Leg Ulcers

1. Clinical Overview

Summary

Venous leg ulcers (VLU) represent the most common form of lower extremity ulceration, accounting for approximately 70-80% of all chronic leg ulcers. [1,2] They arise as a consequence of chronic venous insufficiency (CVI)—a state of sustained ambulatory venous hypertension resulting from valvular incompetence (reflux), venous outflow obstruction (commonly post-thrombotic), or calf muscle pump dysfunction. [3]

The pathognomonic presentation comprises a shallow, exudating ulcer typically located in the "gaiter area" (distal third of the leg, particularly the medial malleolar region), surrounded by characteristic stigmata of chronic venous disease including haemosiderin deposition, lipodermatosclerosis, varicose eczema, and visible varicosities. [4]

The cornerstone of management is compression therapy, which physiologically counteracts ambulatory venous hypertension. Modern evidence from the EVRA (Early Venous Reflux Ablation) trial has revolutionized practice by demonstrating that early endovenous ablation of superficial venous reflux significantly accelerates ulcer healing compared to compression alone or delayed intervention. [5] Despite optimal treatment, healing is typically slow (weeks to months), and recurrence rates exceed 70% within 5 years if compression therapy is discontinued, underscoring the chronic relapsing nature of this condition. [6]

Key Facts

Epidemiology & Burden

• Prevalence: 1-1.3% of adult population; increases to 3-5% in those aged > 80 years [1,2]
• Healthcare Cost: Consumes 1-3% of total healthcare budgets in developed nations (predominantly nursing time for serial dressing changes) [7]
• Recurrence: 60-70% at 5 years without lifelong compression [6]

Pathophysiology

• Mechanism: Ambulatory venous hypertension (normally walking drops venous pressure to ~20mmHg; in CVI remains > 60-90mmHg) [8]
• Classic Site: Medial gaiter area (2-6cm above medial malleolus)—site of incompetent perforating veins (Cockett's perforators) [9]

Diagnosis & Risk Stratification

• ABPI Assessment: Mandatory before compression
  • 0.8-1.2: Safe for full compression (40mmHg at ankle)
  • 0.5-0.8: Mixed disease; reduced compression (20mmHg)
  • less than 0.5: Critical ischaemia; compression contraindicated [10]

  • 1.3: Non-compressible (calcified) vessels; unreliable measurement [10]

Evidence-Based Treatment

• Gold Standard: Multi-layer compression bandaging (e.g., 4-layer system achieving 40mmHg at ankle, graduating to 20mmHg at calf) [11]
• Key Trial: EVRA Trial (NEJM 2018)—early superficial venous ablation reduces median healing time from 82 to 56 days [5]
• Adjunctive Pharmacotherapy: Pentoxifylline 400mg TDS improves healing rates when added to compression (NNT=5-6) [12]

Clinical Pearls

"ABPI First, Compress Second": NEVER apply compression without first confirming adequate arterial inflow. An ABPI less than 0.5 with high compression will reduce perfusion pressure below critical capillary closing pressure (~30mmHg), precipitating tissue necrosis and gangrene. If pulses are impalpable or ABPI is borderline, seek urgent vascular surgical assessment. [10]

"The Champagne Bottle Leg": Advanced lipodermatosclerosis produces characteristic tapering of the lower calf with a narrow "woody" area around the ankle, while the upper calf remains bulky—resembling an inverted champagne bottle. This finding indicates severe, chronic venous disease and predicts difficult-to-heal ulceration. [13]

"Pain Pattern Distinguishes Venous from Arterial": Venous ulcers cause aching, "bursting" pain that is relieved by elevation (gravity-assisted venous drainage). If pain is severe, constant, and worse with elevation, suspect an arterial component, superimposed infection, or inflammatory ulcers (e.g., pyoderma gangrenosum). [14]

"Rule Out Malignant Transformation": Any ulcer present for > 3 months, or any ulcer with raised/rolled/everted edges, mandates edge biopsy to exclude Marjolin's ulcer—squamous cell carcinoma arising in chronic wounds. The risk of malignant transformation in chronic leg ulcers is approximately 0.5-2% but increases with ulcer duration. [15]

"Phlebolymphoedema—Not Just Veins": In long-standing venous disease, the lymphatic system becomes overwhelmed ("secondary lymphoedema"), resulting in "phlebolymphoedema." Compression therapy addresses both venous hypertension and lymphatic congestion, explaining why compression dramatically improves limb volume. [16]

"Contact Dermatitis is Common": Up to 60% of patients with chronic leg ulcers develop allergic contact dermatitis to wound care products (lanolin, preservatives, adhesives, topical antibiotics like neomycin). If the peri-ulcer skin becomes acutely red and itchy despite compression, consider allergy and patch testing. [17]

---

2. Epidemiology & Healthcare Impact

Prevalence & Incidence

Venous leg ulceration represents a major public health burden, particularly in aging populations:

Incidence: Approximately 0.76 per 1,000 person-years, with marked increase in the elderly (> 3 per 1,000 person-years in those aged > 65). [1]

Economic Burden

The financial impact of venous leg ulceration is substantial:

• Estimated 1-3% of total healthcare expenditure in Western countries [7]
• Annual cost per patient ranges from $10,000-15,000 USD (predominantly community nursing for weekly dressings) [7]
• Mean healing time: 12-24 weeks with optimal compression; longer (> 6 months) in 15-20% of cases [19]
• Recurrence rates: 60-70% at 5 years drive ongoing costs [6]

Risk Factors

Venous System Pathology

• Prior DVT: 30-50% of patients with DVT develop post-thrombotic syndrome; of these, 5-10% progress to ulceration [20]
• Varicose Veins: Superficial venous incompetence (long saphenous vein, short saphenous vein) increases risk 3-6 fold [4]
• Superficial Thrombophlebitis: Particularly if recurrent

Mechanical & Lifestyle Factors

• Obesity (BMI > 30): Increases intra-abdominal pressure, impairing venous return; OR 2.0-3.0 [2]
• Prolonged Standing (occupational): Sustained gravitational stress on venous system
• Reduced Ankle Mobility: "Shuffle walking" in elderly—calf pump dysfunction [8]
• Multiple Pregnancies: Progesterone-mediated venous laxity + uterine compression of IVC [18]

Demographic & Genetic

• Advanced Age: Valvular degeneration; reduced mobility
• Female Sex: Hormonal influences (estrogen/progesterone on vein wall compliance)
• Family History: Genetic predisposition to venous valve incompetence

Trauma

• Minor Trauma: The "trigger" in an already congested limb—often a minor knock or scratch initiates ulceration [4]

---

3. Pathophysiology: The Pressure Cooker Model

Understanding the pathophysiology of venous leg ulceration requires appreciation of normal venous return mechanisms and how their failure leads to tissue injury.

Normal Venous Return: The Calf Muscle Pump

Blood in the lower limb must overcome an 80-100mmHg hydrostatic column to return to the heart. [8] This is achieved through:

1. Calf Muscle Pump: Contraction of gastrocnemius and soleus compresses deep veins (posterior tibial, peroneal), propelling blood proximally
2. One-Way Valves: Bicuspid valves in deep, superficial, and perforating veins prevent retrograde flow
3. Pressure Gradient: Normal ambulatory venous pressure drops from ~90mmHg (standing at rest) to ~20-30mmHg during walking (effective pump) [8]

Pathology: Ambulatory Venous Hypertension

Chronic venous insufficiency arises when this elegant system fails due to:

1. Valvular Incompetence (Reflux)

• Primary Valve Failure: Degenerative changes; idiopathic weakness of valve leaflets
• Post-Thrombotic Valve Destruction: DVT damages valves; ~30% develop CVI [20]
• Result: Retrograde flow during muscle relaxation; sustained high pressure

2. Venous Outflow Obstruction

• Post-Thrombotic Occlusion: Residual thrombus or venous stenosis
• Extrinsic Compression: Pelvic masses; May-Thurner syndrome (left common iliac vein compression)
• Result: Impaired forward flow; pressure builds distally

3. Calf Pump Failure

• Reduced Mobility: "Shuffle walking" in elderly or neurological impairment
• Ankle Arthropathy: Reduced range of motion diminishes pump efficiency
• Result: Venous stasis despite competent valves [8]

The Critical Perforators: Cockett's and Beyond

Perforating veins connect superficial and deep systems. Normally, one-way valves allow flow only from superficial → deep.

In CVI, perforator incompetence allows high-pressure deep venous blood to reflux into low-pressure superficial system, particularly at:

• Cockett's perforators (medial calf, 7-25cm above medial malleolus)—most common site [9]
• Boyd's perforator (upper calf, below knee)
• Dodd's perforator (mid-thigh)

Pathological Consequence: The "blowout" of these perforators creates focal areas of extreme venous hypertension in the gaiter region—precisely where ulcers form. [9]

Microvascular Injury: From Pressure to Ulceration

Sustained ambulatory venous hypertension (> 60-90mmHg instead of normal ~20mmHg) [8] triggers a cascade of microvascular injury:

Fibrin Cuff Theory [21]

• High capillary pressure → Increased permeability → Extravasation of fibrinogen
• Pericapillary fibrin deposition forms a physical barrier to oxygen/nutrient diffusion
• Tissue hypoxia → Ulceration

White Cell Trapping Hypothesis [22]

• Venous hypertension → Capillary dilatation → Reduced shear stress
• Leucocytes adhere to endothelium and become "trapped"
• Activated leucocytes release proteolytic enzymes (elastase, matrix metalloproteinases) and reactive oxygen species
• Direct tissue destruction and inflammation

Trap Hypothesis (Modern Synthesis) [22]

• Macromolecules (α2-macroglobulin, fibrinogen) leak into dermis
• Sequester growth factors (TGF-β, VEGF), preventing wound healing
• Creates a pro-inflammatory, anti-healing microenvironment

Final Common Pathway: Chronic inflammation, impaired angiogenesis, fibrosis (lipodermatosclerosis), and ultimately skin breakdown with non-healing ulceration. [3]

---

4. Clinical Presentation

Classic Ulcer Characteristics

Location

• Medial gaiter area (60-70%): Site of Cockett's perforators, 2-6cm above medial malleolus [4,9]
• Lateral gaiter area (20-25%): Short saphenous incompetence or lateral perforators
• Anterior shin/other sites (10-15%): Often traumatic initiation

Morphology

• Edge: Shallow, sloping, irregular (cf. arterial: "punched out"; malignant: rolled/everted) [4]
• Base: Granulation tissue (red, beefy appearance) if healing; slough (yellow fibrinous material) if chronic/infected
• Depth: Usually shallow (confined to dermis); if deep to fascia, suspect arterial insufficiency or infection
• Surrounding Skin: See stigmata of CVI below

Exudate

• Typically heavy exudate (high capillary permeability)
• Serous or serosanguinous
• If purulent → Suspect superimposed infection

Pain Characteristics

Typical Venous Pattern

• Aching, "bursting" sensation—reflects venous distension [14]
• Worse at end of day (gravitational pooling)
• Relieved by elevation (gravity-assisted drainage)
• Worse with dependency (standing/sitting with legs down)

Atypical Pain (Red Flags)

• Severe, constant pain despite elevation → Consider:
  • Arterial insufficiency (mixed ulcer)
  • Infection (cellulitis, osteomyelitis if chronic)
  • Pyoderma gangrenosum (inflammatory)
  • Marjolin's ulcer (malignancy) [14,15]

Stigmata of Chronic Venous Insufficiency (CEAP C4-C6)

1. Haemosiderin Deposition

• Appearance: Brown/reddish-brown skin discoloration [4]
• Pathophysiology: Red cell extravasation → Macrophage phagocytosis → Iron (haemosiderin) deposition in dermis
• Distribution: Gaiter area, often bilateral
• Permanence: Irreversible pigmentation

2. Varicose Eczema (Stasis Dermatitis)

• Appearance: Erythematous, scaling, itchy patches [4]
• Pathophysiology: Inflammatory response to extravasated proteins; contact sensitization to wound care products
• Risk: Precedes ulceration in many cases
• Management: Emollients; topical corticosteroids (if no ulcer); avoid sensitizers

3. Atrophie Blanche

• Appearance: White, atrophic, porcelain-like scars with surrounding hyperpigmentation and telangiectasia (red capillary dots) [4]
• Pathophysiology: Capillary thrombosis → Dermal infarction → Scarring
• Significance: Marker of severe disease; indicates areas of healed micro-ulceration

4. Lipodermatosclerosis (LDS)

• Appearance: Indurated, woody, hyperpigmented skin; inverted champagne bottle/bowling pin configuration [13]
• Pathophysiology: Chronic inflammation → Subcutaneous fibrosis
  • "Acute phase ("hypodermitis"): Tender, red, warm → Often misdiagnosed as cellulitis"
  • "Chronic phase: Hard, bound-down skin; reduced subcutaneous tissue"
• Significance: Predicts poor healing; severe CVI

5. Corona Phlebectatica (Malleolar Flare)

• Appearance: Fan-shaped network of small intradermal veins at medial/lateral ankle [4]
• Significance: Early sign of venous hypertension; may precede ulceration

6. Varicose Veins

• Visible, tortuous, dilated superficial veins (long saphenous, short saphenous distribution)
• Indicates superficial venous incompetence—target for early ablation [5]

---

5. Clinical Assessment & Differential Diagnosis

Structured Vascular Examination

1. Inspection

• Ulcer characteristics (site, size, edge, base, exudate)
• Stigmata of CVI (as above)
• Evidence of arterial disease: Hair loss, skin atrophy, pallor, dependent rubor
• Neuropathic signs: Claw toes, Charcot arthropathy, calluses (pressure points)

2. Palpation

• Pulses: Dorsalis pedis (DP), posterior tibial (PT), popliteal, femoral
  • If both DP and PT palpable → ABPI likely > 0.8 (but measure to confirm) [10]
  • If absent → Urgent ABPI; suspect PAD
• Skin Temperature: Cool → Arterial insufficiency; warm → Venous/inflammatory
• Ulcer Base: Probe depth (exposed bone/tendon suggests osteomyelitis or ischaemia)
• Lipodermatosclerosis: Woody induration

3. Sensation

• 10g Monofilament Test: Screen for peripheral neuropathy (diabetic foot ulcer mimic)
• Pinprick: Gross sensory assessment

4. Ankle-Brachial Pressure Index (ABPI)

Critical Pre-Compression Assessment [10]

Technique:

1. Patient supine, rested 10 minutes
2. Measure brachial SBP in both arms using sphygmomanometer and handheld Doppler (8MHz probe)
3. Use highest brachial pressure as denominator
4. Measure ankle pressures: DP and PT in each leg
5. Use highest ankle pressure for each leg as numerator
6. ABPI = Highest Ankle SBP / Highest Brachial SBP

Interpretation:

Pitfalls:

• Diabetes/Renal Failure: Medial arterial calcification → Falsely elevated ABPI (> 1.3) → Use toe-brachial index (TBI > 0.7 = adequate) or transcutaneous oxygen pressure (TcPO₂ > 30mmHg = adequate) [10]
• Operator Error: Incorrect cuff size, inadequate rest period, using lowest (not highest) pressures

Differential Diagnosis of Leg Ulcers

Venous vs. Arterial vs. Neuropathic vs. Other

Other Important Differentials [23]

Inflammatory/Vasculitic

• Pyoderma Gangrenosum: Rapidly enlarging, very painful, violaceous undermined edge; associated with IBD, RA, haematological malignancy; biopsy shows neutrophilic infiltrate [23]
• Vasculitic Ulcers: ANCA-associated vasculitis, rheumatoid vasculitis, polyarteritis nodosa; usually painful, multifocal, systemic features

Malignant

• Marjolin's Ulcer: SCC in chronic wound (0.5-2% of chronic leg ulcers); raised/everted edges [15]
• Basal Cell Carcinoma: Rodent ulcer; rolled pearly edge
• Melanoma: Pigmented lesion; irregular

Infection

• Chronic Osteomyelitis: Deep, persistent ulcer; exposed bone; probe-to-bone positive
• Mycobacterial: TB, atypical mycobacteria (e.g., M. marinum)

Metabolic/Haematological

• Sickle Cell Ulcers: Lateral malleolus; young patients of African descent
• Diabetic Foot Ulcers: Neuropathic ± arterial component

Other

• Trauma: Factitious ulcers (self-inflicted; geometric shapes; healing when protected)
• Necrobiosis Lipoidica: Diabetic; shiny, yellow-brown plaques; ulcerate if traumatized
• Livedoid Vasculopathy: Atrophie blanche-like lesions; young females; hypercoagulable

Clinical Approach to Atypical Ulcers:

• Non-healing despite adequate compression
• Unusual site
• Severe pain out of proportion to appearance
• Systemic features
• Young patient without venous risk factors → Biopsy (edge and base) + autoimmune screen (ANA, ANCA, RF) + consider specialist referral [23]

---

6. Investigations

Mandatory Baseline Investigations

1. Ankle-Brachial Pressure Index (ABPI)

• When: ALL patients with leg ulceration before initiating compression [10]
• Purpose: Exclude significant arterial disease
• Technique: As described above
• Repeat: If clinical change (worsening symptoms, new ulceration)

2. Venous Duplex Ultrasound

• When: All venous leg ulcers (ideally within 2 weeks to enable early ablation per EVRA) [5]
• Purpose: Map venous anatomy and identify reflux/obstruction
• Assessed Systems:
  • "Deep Veins: Patency (exclude DVT, post-thrombotic obstruction), reflux (valve incompetence)"
  • "Superficial Veins: Long saphenous vein (LSV), short saphenous vein (SSV), anterior accessory saphenous vein—assess for reflux (> 0.5 seconds reverse flow on calf squeeze/Valsalva) [24]"
  • "Perforating Veins: Identify incompetent perforators (Cockett's, Boyd's, Dodd's)—diameter > 3.5mm + reflux > 0.5 sec [9]"
• Results Guide:
  • Isolated superficial reflux → Early ablation (EVLT, RFA, foam sclerotherapy) [5]
  • Deep vein obstruction → Consider venoplasty/stenting in specialist centers
  • Deep vein reflux → Compression ± consider deep vein reconstruction (selected cases)

Adjunctive/Selective Investigations

Laboratory Tests

Indications for Blood Tests:

• Delayed healing
• Atypical features
• Systemic symptoms

Microbiological Investigations

Wound Swab/Culture [25]

• Indication: Clinical signs of infection:
  • Spreading erythema (cellulitis)
  • Pyrexia
  • Rapid ulcer expansion
  • Purulent discharge
  • Systemic sepsis
• NOT Indicated: Routine swabbing of non-infected ulcers
  • "Rationale: All chronic wounds are colonized with bacteria (biofilms); positive swabs without clinical infection lead to unnecessary antibiotic use and resistance [25]"
• Key Principle: "Treat the patient, not the swab"

Deep Tissue Biopsy/Bone Biopsy

• Indication: Suspected osteomyelitis (probe-to-bone positive; non-healing despite treatment; exposed bone)
• Gold Standard: Bone culture + histology

Ulcer Biopsy [15,23]

Indications:

• Non-healing > 3 months despite adequate compression
• Atypical features: Raised/rolled/everted edges (Marjolin's ulcer), rapid progression, severe pain
• Suspected malignancy: Any ulcer with irregular pigmentation, nodularity, bleeding
• Suspected vasculitis/PG: For histological diagnosis

Technique:

• Edge biopsy (4-6mm punch): Include ulcer edge + adjacent normal skin
• Base biopsy: If suspected malignancy/deep pathology
• Send in formalin for histology ± fresh tissue for culture if infection suspected

Histology Findings:

• SCC (Marjolin's): Atypical keratinocytes, invasion
• Vasculitis: Fibrinoid necrosis, vessel inflammation
• PG: Neutrophilic dermatosis

Advanced/Specialist Investigations

Transcutaneous Oxygen Pressure (TcPO₂)

• Indication: Non-compressible vessels (ABPI > 1.3); assess tissue oxygenation
• Interpretation: TcPO₂ > 30mmHg predicts healing; less than 20mmHg poor healing [26]

Toe-Brachial Index (TBI)

• Indication: Calcified arteries (diabetes, renal failure) where ABPI unreliable
• Technique: Photoplethysmography on great toe; TBI > 0.7 = adequate arterial supply [10]

CT/MR Venography

• Indication: Suspected iliac vein obstruction (post-thrombotic, May-Thurner syndrome); pre-operative planning for venous reconstruction
• Findings: Stenosis, occlusion, collaterals

Air Plethysmography

• Indication: Research/specialist assessment of venous hemodynamics
• Measurements: Venous filling index, ejection fraction, residual volume fraction

---

7. Management: A Multimodal Approach

Treatment Principles

Goal: Lower ambulatory venous pressure to allow ulcer healing and prevent recurrence [3]

Mechanisms:

1. External Compression: Opposes hydrostatic pressure; restores valve function
2. Correct Underlying Reflux: Ablate incompetent superficial veins
3. Optimize Wound Environment: Appropriate dressings; manage infection/biofilm
4. Address Comorbidities: Nutrition, mobility, obesity, edema

1. Compression Therapy: The Cornerstone

Rationale [11]

• Applies graduated external pressure (highest at ankle, decreasing proximally)
• Reduces venous diameter → Improves valve coaptation → Reduces reflux
• Enhances calf muscle pump efficiency
• Reduces ambulatory venous pressure from ~80mmHg to ~30mmHg [8]
• Reduces edema → Improves lymphatic drainage

Evidence:

• Cochrane Review (2014): Compression significantly increases ulcer healing vs. no compression (RR 1.6-2.0) [11]
• Multi-layer > Single-layer: 4-layer systems superior to single elastic bandage [11]
• High compression > Low compression (if ABPI permits): 40mmHg > 20mmHg for healing rate [11]

4-Layer Bandaging (e.g., Profore System)

Layers (ankle to knee):

1. Orthopaedic Wool/Padding: Absorbs exudate; protects bony prominences; increases limb circumference (reduces pressure per Laplace's Law)
2. Crepe Bandage: Smooths layer 1; provides gentle compression
3. Class 3a Elastic Bandage: Provides sustained compression (at rest and during activity)
4. Cohesive Elastic Bandage: Secures layers; provides additional compression

Application Technique:

• Apply with 50% overlap (spiral technique)
• Ankle pressure: 40mmHg (achieved by appropriate tension + spiral overlap)
• Calf pressure: Graduated reduction to ~20mmHg
• Change frequency: Weekly (or sooner if "slippage" or strike-through)

Alternative Compression Systems:

• Short-Stretch Bandages: High working pressure (during activity); low resting pressure; require active patient
• 2-Layer Kits: Simpler; some evidence of equivalence to 4-layer [27]
• Compression Hosiery: Class 2 (20-30mmHg) or Class 3 (30-40mmHg) as alternative; requires dexterity for application; suits mobile patients with smaller ulcers [27]
• Single-Component Systems: UrgoK1 (multicomponent in one bandage) demonstrated 91% median wound area reduction at 6 weeks; high patient satisfaction and adherence [36]
• Intermittent Pneumatic Compression: Adjunct in refractory cases

Contraindications to Full Compression (40mmHg):

• ABPI less than 0.5: Absolute contraindication (critical ischaemia) [10]
• ABPI 0.5-0.79: Relative; use reduced compression (20mmHg) with caution OR refer vascular first
• Decompensated Heart Failure: Risk of pulmonary edema if mobilizing large volume of fluid
• Acute DVT: Wait until anticoagulated and acute inflammation settled (2 weeks); then compression aids post-thrombotic syndrome prevention
• Severe Peripheral Neuropathy: Risk of undetected pressure injury
• Local Infection/Cellulitis: Relative; treat infection first, then compress

Practical Tips:

• Padding Bony Prominences: Extra padding over malleoli, tibial crest to prevent pressure ulceration
• Patient Education: Explain rationale (pressure-lowering), importance of keeping bandages dry, when to seek review (too tight, pain, strike-through)
• Elevation: Supplement compression with leg elevation when resting ("toes above nose")

2. Wound Bed Preparation

TIMERS Framework [28]

Dressing Selection [28]

Principles:

• Moist wound environment optimizes healing
• Manage exudate without desiccation or maceration
• Simple is often best (avoid expensive advanced dressings unless indicated)

Common Dressing Types:

Avoid:

• Topical Antibiotics (Neomycin, Fusidic acid): High rates of contact sensitization; promote resistance [17]
• Antiseptics (full-strength Betadine, Hydrogen peroxide): Cytotoxic to fibroblasts
• Dry Gauze: Adheres to wound; traumatic removal; desiccates tissue

Debridement [28]

• Sharp Debridement: Surgical removal of slough/fibrin; promotes healing by removing biofilm and senescent cells; perform if adequate arterial supply
• Larvotherapy: Sterile maggots (Lucilia sericata) secrete proteolytic enzymes; highly effective for sloughy wounds; patient acceptability variable

3. Early Venous Reflux Ablation: The EVRA Paradigm Shift

Historical Context:

• Traditional teaching: Delay superficial venous surgery until ulcer heals (concern about wound complications)
• EVRA Trial (2018) challenged this dogma [5]

EVRA Trial: Key Evidence [5,38]

2023-2024 Network Meta-Analysis Evidence [38]:

• 17 studies, 2156 patients: Systematic review comparing RFA, EVLA, sclerotherapy, surgery vs. compression monotherapy
• Ulcer Healing: RFA superior to compression alone (OR 5.80, 95% CI 1.08-35.07)
• Recurrence Prevention: EVLA ranked highest (SUCRA 69.65); EVLA (RR 0.06, 95% CI 0.00-0.57), sclerotherapy (RR 0.07), and RFA (RR 0.12) all significantly reduced recurrence vs. compression monotherapy
• Safety: EVLA had higher complication rate vs. compression (RR 14.3, 95% CI 2.03-172.56), though absolute risk remains low

Technique Options (for superficial venous reflux):

1. Endovenous Thermal Ablation

• Endovenous Laser Therapy (EVLT): Laser fiber inserted via ultrasound-guided access; thermal energy ablates vein wall [29]
• Radiofrequency Ablation (RFA): Similar principle; radiofrequency catheter
• Advantages: Minimally invasive; local anaesthetic; day-case; success rates > 90% at 5 years
• Complications: Thrombophlebitis (common, self-limiting), DVT (less than 1%), skin burns (rare)

2. Ultrasound-Guided Foam Sclerotherapy

• Injection of foam sclerosant (sodium tetradecyl sulfate, polidocanol) into incompetent vein under ultrasound
• Advantages: No thermal energy; office-based; lower cost
• Disadvantages: Higher recurrence vs. thermal ablation (~20-30% at 5 years); risk of visual disturbance (migraine-like, ~1%); rare risk of stroke (paradoxical embolism via PFO)

3. Phlebectomy

• Stab avulsion of varicosities under local anaesthetic
• Often combined with ablation

Recommendations [5,24]:

• All venous leg ulcers: Arrange duplex within 2 weeks
• If superficial reflux identified: Refer for early ablation (accelerates healing, reduces recurrence)
• Continue compression throughout and after ablation

4. Pharmacological Adjuncts

Pentoxifylline (Trental) [12,39]

Other Agents (Limited Evidence):

• Aspirin 300mg daily: Small trial suggested benefit; unclear mechanism; not routinely recommended [30]
• Micronized Purified Flavonoid Fraction (MPFF): Venotonic; some RCT evidence in CVI symptoms; limited data for ulcer healing
• Statins: Theoretical anti-inflammatory benefit; no RCT evidence

NOT Recommended:

• Topical Growth Factors: Expensive; no consistent benefit
• Systemic Antibiotics (in absence of infection): No benefit; promotes resistance [25]

5. Adjunctive/Advanced Therapies

Skin Grafting [31]

Indications:

• Large ulcers (> 10cm²)
• Non-healing despite 3-6 months of compression
• Clean, granulating wound bed ("stuck" but healthy)

Techniques:

• Split-Thickness Skin Graft (SSG): Harvested from thigh using dermatome; meshed (1:1.5 or 1:3 expansion) to cover large areas
• Pinch Grafting: Multiple small (5-10mm) full-thickness grafts harvested under local; seeds granulation tissue
• Tissue-Engineered Skin: Dermagraft, Apligraf (bioengineered skin substitutes); very expensive; limited evidence

Critical Point: Compression MUST continue post-grafting; otherwise graft fails and recurrence inevitable [31]

Negative Pressure Wound Therapy (NPWT)

• Promotes granulation; manages exudate
• May accelerate healing in selected large/complex ulcers
• Requires adequate arterial supply (ABPI > 0.8)

6. Lifestyle & Supportive Measures

Leg Elevation

• Elevate legs above heart level when resting ("toes above nose")
• Reduces hydrostatic pressure; aids venous/lymphatic drainage
• Minimum 30 minutes TDS; ideally 2-3 hours/day

Exercise & Ankle Mobility

• Activate calf pump: Ankle dorsiflexion/plantarflexion exercises (10 reps/hour)
• Walking (with compression applied): Enhances pump efficiency
• Physiotherapy if ankle stiffness/reduced ROM

Weight Reduction (if BMI > 30)

• Reduces intra-abdominal pressure; improves mobility; reduces venous hypertension [2]

Nutritional Optimization

• Protein: 1.2-1.5g/kg/day (wound healing requires synthesis)
• Vitamin C: 500mg daily (collagen synthesis)
• Zinc: If deficient (delayed healing); 50mg elemental zinc daily
• Correct Anemia: Target Hb > 10g/dL (oxygen delivery to wound)

---

8. Complications & Challenges

Non-Healing/Refractory Ulcers

Definition: Ulcer failing to reduce in size by > 30% after 4-6 weeks of optimal compression [19]

Differential Diagnosis:

1. Inadequate Compression: Patient non-concordance; slipped bandages; inappropriate low compression
2. Occult Arterial Disease: Repeat ABPI; consider advanced arterial imaging
3. Unaddressed Superficial Reflux: Ensure duplex performed; consider ablation
4. Infection: Biofilm, cellulitis, osteomyelitis
5. Malignant Transformation (Marjolin's ulcer): Biopsy [15]
6. Inflammatory Ulcer: Pyoderma gangrenosum, vasculitis [23]
7. Systemic Factors: Malnutrition (albumin less than 30g/L), anaemia (Hb less than 10g/dL), diabetes (HbA1c > 75mmol/mol), immunosuppression

Approach:

• Reassess ABPI (arterial disease may progress)
• Repeat Duplex (check for missed reflux/obstruction)
• Biopsy (exclude malignancy/vasculitis)
• Bloods: FBC, albumin, HbA1c, CRP, autoimmune screen
• Optimize Compression: Consider compliance aids (e.g., Velcro wrap systems)
• Consider Skin Grafting (if clean granulating base)
• Refer to Specialist: Wound clinic, dermatology, vascular surgery

Infection

Colonization vs. Infection [25]

All chronic wounds are colonized with bacteria (biofilms: Staphylococcus aureus, Pseudomonas, anaerobes).

• Colonization: Bacteria present but no tissue invasion; no systemic response; does not require antibiotics
• Infection: Tissue invasion + host response; requires treatment

Clinical Signs of Infection:

• Cellulitis: Spreading erythema, warmth, tenderness beyond ulcer margin; fever
• Increased Pain: Out of proportion to usual
• Purulent Discharge: Thick, opaque exudate
• Rapid Deterioration: Ulcer expansion, increased necrosis
• Systemic: Fever, rigors, tachycardia (sepsis)

Management:

• Wound Swab/Culture: Guide antibiotic choice (if infection present)
• Systemic Antibiotics [25]:
  • "Empirical (pending culture): Flucloxacillin 500mg QDS (covers S. aureus) ± Penicillin V (covers Streptococcus)"
  • "If Pen-allergic: Clarithromycin 500mg BD or Doxycycline 200mg stat then 100mg daily"
  • "If MRSA: Doxycycline or Vancomycin (IV)"
  • "Duration: 7-14 days (depending on severity)"
• Debridement: Remove slough/biofilm (harbors bacteria)
• Continue Compression (unless systemic sepsis requiring admission)

Osteomyelitis (Chronic Ulcer Complication) [32]

• Suspect If: Probe-to-bone positive; exposed bone; non-healing despite treatment; raised inflammatory markers
• Diagnosis: MRI (gold standard); bone biopsy + culture
• Treatment: Prolonged antibiotics (6 weeks IV then oral) ± surgical debridement; requires specialist input

Contact Dermatitis

Epidemiology: Affects up to 60% of chronic leg ulcer patients [17]

Common Allergens:

• Topical Antibiotics: Neomycin, Fusidic acid, Gentamicin (highest sensitization rates)
• Preservatives: Parabens, methylisothiazolinone (in wound care products)
• Adhesives: Colophony, rubber compounds (in bandages/tapes)
• Lanolin: Wool alcohol (in emollients)
• Fragrances: In creams

Clinical Features:

• Acute worsening of eczema confined to area of dressing application
• Itching, erythema, vesicles
• May mimic infection but no systemic features

Management:

• Stop Culprit Agent: Review all topical products
• Patch Testing: Refer dermatology for formal testing (leg ulcer series)
• Switch to Hypoallergenic Products: Simple emollients (50:50 white soft paraffin:liquid paraffin), non-sensitizing dressings
• Topical Corticosteroids: Betamethasone valerate 0.1% to peri-ulcer skin (not directly on ulcer) for eczema

Prevention:

• Avoid topical antibiotics
• Use simple, fragrance-free products
• Minimize adhesive contact with skin

Recurrence

Epidemiology: 60-70% of healed venous ulcers recur within 5 years if compression discontinued [6]

Risk Factors for Recurrence:

• Non-compliance with compression hosiery (most important)
• Persistent superficial reflux (not ablated)
• Deep venous reflux/obstruction (post-thrombotic syndrome)
• Large initial ulcer (> 10cm²)
• Duration > 12 months before healing
• Obesity, immobility

Prevention Strategies [6]:

1. Lifelong Compression Hosiery:
   • Class 2 (20-30mmHg) minimum; Class 3 (30-40mmHg) if tolerated
   • Application: Daily, from waking to bedtime
   • Replace: Every 3-6 months (loses elasticity)
   • Compliance Aids: Donning devices (e.g., Medi Butler), toe-less stockings, Velcro wraps if dexterity issues
2. Early Venous Ablation: Reduces recurrence from 28% to 12% at 4 years (ESCHAR Trial) [33]
3. Weight Loss: If obese
4. Ankle Mobility Exercises: Maintain calf pump function
5. Early Detection: Regular podiatry/nurse follow-up; treat minor trauma/skin breakdown immediately

Patient Education:

• Emphasize: Compression is for life, not just until healing
• Skin Care: Daily emollients; avoid trauma; check feet/legs daily

---

9. Prognosis & Long-Term Outcomes

Healing Rates

With Optimal Compression [19]:

• 12 weeks: ~50% healed
• 24 weeks: ~70% healed
• 12 months: ~85% healed
• Refractory (> 12 months): 10-15% remain unhealed despite best therapy

With Early Venous Ablation (EVRA) [5]:

• Median healing time: 56 days (vs. 82 days with deferred ablation)
• 24-week healing: 85.6% (vs. 76.3%)

Factors Predicting Poor Healing

Recurrence & Long-Term Management

Recurrence Rates [6,33]:

• No compression after healing: ~70% recurrence at 5 years
• With compression hosiery: ~30% recurrence at 5 years
• With compression + venous ablation: ~12% recurrence at 4 years [33]

Surveillance:

• First year post-healing: Review every 3 months (high-risk period)
• Thereafter: 6-12 monthly if stable
• Monitor: Skin integrity, compression compliance, new varicosities

Quality of Life Impact

Chronic venous leg ulceration profoundly affects quality of life [34,37]:

• Pain: Chronic, impacts sleep and daily activities
  • "Systematic Review (2024): Impact of compression on QoL and pain shows heterogeneous results; studies using EuroQol-5D, VEINES-QOL, SF-36, and CIVIQ-20 demonstrated QoL improvements with compression, while Cardiff Wound Impact Schedule and SF-8/SF-12 showed no difference between groups [37]"
  • "Pain Relief: Mixed evidence—some studies show reduction with compression, others report no change; pain management remains individualized [37]"
• Mobility: Reduced due to pain, bulky bandages
• Social Isolation: Malodor from exudate; body image concerns; depression (prevalence ~25%)
• Work/Economic: Time off for dressing changes; early retirement
• Healthcare Burden: Weekly nurse visits; recurrent hospitalizations for cellulitis

Holistic Management:

• Pain Control: Analgesia (avoid NSAIDs if elderly/renal impairment); elevation
• Psychological Support: Screen for depression; consider CBT, support groups
• Social Care: Assess need for mobility aids, home adaptations
• Occupational Therapy: Compression stocking application aids; footwear advice

---

10. Classification Systems

CEAP Classification (Chronic Venous Disorders) [35]

Clinical, Etiological, Anatomical, Pathophysiological

Clinical Classification (C0-C6):

Venous leg ulcer = C6

Etiology (E):

• Ec: Congenital
• Ep: Primary (idiopathic; no known cause)
• Es: Secondary (post-thrombotic, traumatic)

Anatomy (A):

• As: Superficial veins
• Ad: Deep veins
• Ap: Perforating veins

Pathophysiology (P):

• Pr: Reflux
• Po: Obstruction
• Pr,o: Both reflux and obstruction

Example: A patient with active medial malleolar ulcer, post-DVT, with superficial and perforator reflux:

• CEAP: C6, Es, As,p, Pr

Venous Clinical Severity Score (VCSS)

Quantitative score (0-30) assessing 10 clinical attributes:

• Pain, varicose veins, edema, pigmentation, inflammation, induration, number of ulcers, ulcer duration, ulcer size, compression use
• Each scored 0-3
• Higher score = More severe disease
• Useful for tracking treatment response

---

11. Technical Appendix: Compression Bandaging Science

Laplace's Law (Physics of Compression)

Pressure = (Tension × Number of Layers × 4630) / (Circumference × Width)

Where:

• Pressure: Sub-bandage pressure (mmHg)
• Tension: Force applied during bandaging (Newtons)
• Number of Layers: Overlapping spirals (50% overlap = 2 layers)
• Circumference: Leg circumference at point of measurement (cm)
• Width: Bandage width (cm)
• 4630: Constant to convert units

Clinical Implications:

1. Circumference: Smaller circumference (e.g., ankle vs. calf) → Higher pressure

   • Explains graduated compression (naturally higher at ankle if tension constant)
   • Risk: Excessive pressure over bony prominences (tibial crest, malleoli)—requires extra padding to increase local circumference

2. Tension: Apply consistent tension during bandaging to achieve target pressure

   • Too loose: Ineffective
   • Too tight: Arterial compromise, pain, pressure damage

3. Layers: 50% overlap spiral → 2 layers → Doubled pressure

   • Figure-of-8 around ankle → 3-4 layers → Very high pressure (protect with padding)

4. Width: Wider bandage → Lower pressure (for same tension)

   • Narrow bandages concentrate force → Risk of tourniquet effect

Graduated Compression:

• Goal: 40mmHg at ankle, graduating to 20mmHg at knee
• Achieved by: Maintaining constant tension as bandage applied proximally; natural increase in calf circumference reduces pressure per Laplace's Law

Bandage Types

Elastic vs. Inelastic

4-Layer System Combines Both:

• Layers 1-2: Inelastic (padding, crepe)
• Layer 3: Elastic (Class 3a)
• Layer 4: Cohesive elastic
• Result: Balanced resting + working pressure suitable for most patients

---

12. Evidence Base & Guidelines

Key Clinical Guidelines

1. NICE CG168 (2013): Varicose Veins in the Legs [24]

• Recommendation: Offer endovenous ablation (EVLT or RFA) as first-line for varicose veins with reflux
• Compression hosiery for symptom relief; lifelong after ulcer healing
• Refer for vascular ultrasound if leg ulcer + suspected venous disease

2. SIGN Guideline 120 (2010): Management of Chronic Venous Leg Ulcers

• High compression (40mmHg) superior to low compression (if ABPI permits)
• Multi-layer > single-layer systems
• Early referral for duplex; consider venous surgery

3. Cochrane Reviews:

• Compression for venous leg ulcers [11]: Compression increases healing vs. no compression (Level I evidence)
• Pentoxifylline [12]: Adjunctive benefit (Level I evidence)
• Dressings under compression [28]: No clear superiority of advanced dressings over simple non-adherent

Landmark Trials

1. EVRA Trial (Early Venous Reflux Ablation), NEJM 2018 [5]

2. ESCHAR Trial (Effect of Surgery and Compression on Healing And Recurrence), 2007 [33]

3. VenUS I Trial (4-layer vs. Short-Stretch Bandaging), 2004 [27]

Strength of Evidence Summary

---

13. Special Situations & Controversies

Mixed Arterial-Venous Ulcers (ABPI 0.5-0.79)

Challenge: Venous hypertension requires compression, but arterial insufficiency risks ischaemia with full compression [10]

Management:

• Reduced Compression: 20-25mmHg (half standard pressure)
  • Use 2-layer system or reduced tension with 4-layer
• Vascular Referral: Assess arterial disease; consider revascularization (angioplasty, bypass) before full compression
• Monitor Closely: Check for signs of ischaemia (increased pain, tissue necrosis, cool limb)
• Reassess ABPI: Arterial disease may improve post-revascularization, allowing escalation to full compression

Role of Revascularization:

• If significant arterial disease (ABPI less than 0.6, claudication, rest pain) → Revascularize first, then compress
• Angioplasty/stenting of iliac/SFA stenoses can improve ABPI to safe range (> 0.8)

Venous Ulcers in Heart Failure

Concern: Mobilizing large volume of interstitial fluid with compression risks acute pulmonary edema in decompensated heart failure

Approach:

• Optimize Heart Failure First: Diuresis to euvolaemia
• Introduce Compression Gradually: Start with light compression (10-20mmHg); monitor fluid balance, symptoms (dyspnea, orthopnea)
• Multidisciplinary Input: Cardiology, wound care, heart failure nurses
• Patient Education: Report breathlessness immediately

Venous Ulcers in Diabetic Patients

Challenges:

• Calcified Arteries: ABPI > 1.3 unreliable due to medial arterial sclerosis [10]
  • "Solution: Toe-brachial index (TBI > 0.7) or transcutaneous oxygen (TcPO₂ > 30mmHg) to confirm adequate perfusion before compression [26]"
• Neuropathy: Risk of undetected pressure injury from bandages
  • "Solution: Extra padding; educate to report pain (or lack thereof); frequent review"
• Mixed Pathology: Diabetic foot ulcers often have venous + arterial + neuropathic components
  • "Solution: Thorough vascular assessment; multidisciplinary foot team"

Pregnancy & Venous Ulcers

Physiological Changes in Pregnancy:

• Progesterone → Venous smooth muscle relaxation
• Gravid uterus → IVC compression → Increased lower limb venous pressure
• Increased blood volume

Management:

• Compression Safe: No evidence of harm; improves symptoms
• Class 2 Compression Hosiery: Well tolerated; reduces edema
• Avoid Bandaging: Awkward; hosiery preferred
• Postnatal Reassessment: Symptoms often improve post-delivery; reassess need for compression/ablation

---

14. Patient & Caregiver Education

What Causes Venous Leg Ulcers?

The veins in your legs have one-way valves that help blood flow upward to your heart, working against gravity. When these valves become damaged or weak (often from previous blood clots, varicose veins, or simply aging), blood pools in the lower leg. This creates high pressure in the tiny blood vessels near the skin, like a "water hammer" effect. Over time, this pressure damages the skin from the inside, causing it to break down and form an open sore (ulcer) that struggles to heal.

Why Do I Need Compression Bandages?

The ulcer is caused by high pressure in the veins. The only way to lower that pressure and allow healing is to squeeze the veins from the outside. The compression bandages act like a supportive "second skin," helping your leg muscles pump blood back up toward your heart more efficiently. This reduces the pressure that's damaging your skin.

It might feel tight, but it needs to be tight to work. Think of it like squeezing a garden hose—the external pressure helps move the water (blood) along.

How Long Will Healing Take?

Healing is slow. On average:

• Small ulcers: 6-12 weeks with compression
• Large ulcers: 3-6 months or longer

About half of ulcers heal within 3 months with good compression. Some take much longer. Patience and sticking with treatment (even when it feels slow) is crucial.

Will It Come Back?

Yes, there is a high chance of recurrence. About 7 out of 10 people get another ulcer within 5 years if they stop wearing compression after healing.

To prevent recurrence:

1. Wear compression stockings every day for life (from morning to bedtime)
2. Replace stockings every 3-6 months (they lose their squeeze)
3. Elevate your legs when resting (above heart level)
4. Keep active (walking helps the calf pump work)
5. Inspect your legs daily for any new breaks in the skin; report them immediately

Can Surgery Help?

Yes. If we find "leaky" veins (varicose veins or valve failure) feeding the ulcer, we can seal them using a simple laser or injection treatment, usually done under local anesthetic as a day-case. Research shows this helps the ulcer heal faster (about 3 weeks sooner) and stay healed longer (lower recurrence). Your doctor will arrange an ultrasound scan to check if this is suitable for you.

When Should I Seek Help?

Contact your nurse or doctor if:

• The bandage feels too tight (numbness, blue toes, severe pain)
• You develop spreading redness, warmth, or fever (infection)
• The ulcer gets bigger or more painful
• You notice a bad smell (may indicate infection)
• The bandage gets wet or slips down (needs changing)

Living with a Leg Ulcer: Practical Tips

Elevation:

• Raise your legs above your heart for at least 2-3 hours per day (lying on sofa with legs on cushions, or in bed)
• Use a footstool when sitting

Exercise:

• Walk daily (with bandages on—they work best during activity)
• Ankle exercises: Point toes up and down 10 times every hour (activates calf pump)

Skin Care (once ulcer healed):

• Moisturize daily with simple, fragrance-free cream (e.g., 50:50 white soft paraffin/liquid paraffin)
• Avoid scratching (use antihistamines if itchy)
• Avoid minor trauma: Wear protective footwear; be careful around pets, furniture

Nutrition:

• Eat a high-protein diet (meat, fish, eggs, beans—your body needs protein to heal)
• Take a Vitamin C supplement (500mg daily supports healing)
• Drink plenty of fluids

Bathing:

• Keep bandages dry (use plastic bag/shower shield)
• If bandages get wet, contact nurse for change (wet bandages don't compress properly)

Footwear:

• Wear comfortable, well-fitting shoes (avoid tight or rubbing footwear)
• Check inside shoes daily for foreign objects

---

15. Examination Focus (MRCP PACES / MRCS OSCE)

Clinical Examination Scenario

Instruction: "This patient has a chronic leg problem. Please examine the legs and present your findings."

Approach:

1. Introduction & Consent

• Introduce yourself; confirm patient identity
• "I'd like to examine your legs. Is that alright?"
• Position: Lying on couch, legs exposed from groin to feet

2. General Inspection (standing at foot of bed)

• Ulcers: Location (medial gaiter?), size, number
• Skin Changes: Pigmentation, eczema, atrophie blanche, lipodermatosclerosis
• Veins: Varicosities (distribution: long saphenous/short saphenous)
• Limb Shape: Champagne bottle leg?
• Symmetry: Bilateral changes (venous) vs. unilateral (? post-DVT)

3. Close Inspection of Ulcer

• Site: Medial malleolus (venous), lateral (venous/arterial/traumatic), heel/toes (arterial), plantar (neuropathic)
• Size: Measure (cm × cm) if possible
• Edge: Sloping (venous), punched-out (arterial), rolled (SCC), undermined (PG)
• Base: Granulating (healing), sloughy (chronic), necrotic (ischaemia), exposed tendon/bone (deep infection/ischaemia)
• Surrounding Skin: Cellulitis (erythema, warmth), contact dermatitis (eczema confined to bandage area)

4. Palpation

• Temperature: Warm (venous/infection), cool (arterial)
• Skin: Woody induration (lipodermatosclerosis), pitting edema
• Pulses (with 8MHz Doppler if available):
  • Femoral, popliteal, dorsalis pedis, posterior tibial
  • "Key: If DP and PT both palpable → ABPI likely > 0.8; if absent → Suspect PAD"
• Ulcer Base: Gently probe depth (don't cause pain); check for probe-to-bone (osteomyelitis)
• Tenderness: Localized (ulcer itself) vs. diffuse (cellulitis)

5. Sensation (if neuropathic differential)

• 10g monofilament on plantar surface

6. Special Tests

• Trendelenburg Test (if varicosities present; largely historical—duplex has replaced):
  • Elevate leg, empty veins
  • Apply tourniquet at saphenofemoral junction
  • Stand patient up; observe filling
  • Rapid filling despite tourniquet → Perforator/deep incompetence
  • Slow filling, then rapid on tourniquet release → Superficial (SFJ) incompetence
• Tap Test: Tap varicosity proximally; feel impulse distally (confirms incompetence)

7. Complete Examination

• "I would like to complete my examination by:
  • Measuring ABPI with Doppler
  • Examining the abdomen (pelvic mass causing venous obstruction)
  • Performing venous duplex ultrasound"

Sample Presentation

"This is Mrs. X, a 72-year-old lady. On examination, there is a large (~8cm × 5cm) shallow ulcer with a sloping edge and granulating base, located over the medial gaiter area of the right leg, 3cm above the medial malleolus. The surrounding skin demonstrates extensive haemosiderin deposition, varicose eczema, and lipodermatosclerosis with an inverted champagne bottle configuration of the lower calf. There are visible varicose veins in the distribution of the long saphenous vein. Both dorsalis pedis and posterior tibial pulses are palpable. The ulcer is tender but warm, and there is no surrounding cellulitis.

My differential diagnosis is a venous leg ulcer secondary to chronic venous insufficiency, likely with superficial venous reflux.

I would like to measure the ABPI to confirm adequate arterial perfusion before initiating compression, and arrange venous duplex ultrasound to map the venous anatomy and assess for reflux, with a view to early endovenous ablation in line with the EVRA trial evidence."

Viva Voce Questions & Model Answers

Q1: What is the CEAP classification, and how would you classify this patient?

A: CEAP is a standardized classification for chronic venous disorders, covering Clinical, Etiological, Anatomical, and Pathophysiological components.

• Clinical (C0-C6): C6 = active ulcer; C5 = healed ulcer
• Etiology: Congenital, Primary (idiopathic), Secondary (post-DVT, traumatic)
• Anatomy: Superficial, Deep, Perforator veins
• Pathophysiology: Reflux, Obstruction, or both

This patient would be classified as C6 (active ulcer). Based on history/duplex, if post-DVT with superficial and perforator reflux, full classification would be C6, Es, As,p, Pr.

Q2: Why is it essential to measure ABPI before applying compression, and how do you interpret the result?

A: ABPI assessment is mandatory to exclude significant peripheral arterial disease before compression. High compression (40mmHg) in the presence of arterial insufficiency can reduce perfusion pressure below critical closing pressure (~30mmHg), causing tissue ischaemia and gangrene.

Interpretation:

• 1.0-1.2: Normal; safe for full compression (40mmHg)
• 0.8-0.99: Mild PAD; full compression usually safe
• 0.5-0.79: Moderate PAD; reduced compression (20mmHg) or vascular referral first
• less than 0.5: Severe PAD; compression absolutely contraindicated; urgent vascular referral
• > 1.3: Non-compressible vessels (calcification, e.g., diabetes); unreliable—use alternative (toe pressures, TcPO₂)

ABPI is calculated as: Highest ankle SBP / Highest brachial SBP, using handheld Doppler.

Q3: What is the evidence for early venous ablation, and what trial established this?

A: The EVRA trial, published in the New England Journal of Medicine in 2018, was a multicenter randomized controlled trial of 450 patients with venous leg ulcers and superficial venous reflux on duplex.

Intervention: Early endovenous ablation (within 2 weeks) + compression vs. Deferred ablation (after healing or 6 months) + compression

Results: Median time to healing was significantly shorter in the early group (56 days vs. 82 days, pless than 0.0001), and 24-week healing rates were higher (85.6% vs. 76.3%).

Impact: This trial changed practice. We now arrange duplex within 2 weeks and offer early superficial venous ablation (EVLT, RFA, or foam sclerotherapy) to accelerate healing, rather than waiting for the ulcer to heal before treating veins.

Q4: Describe lipodermatosclerosis and explain the "champagne bottle leg."

A: Lipodermatosclerosis is chronic inflammation and fibrosis of the dermis and subcutaneous fat, resulting from long-standing venous hypertension.

Pathophysiology: Chronic extravasation of inflammatory mediators → Subcutaneous fibrosis → Indurated, bound-down skin

Clinical Features:

• Acute phase ("hypodermitis"): Tender, erythematous, warm—often misdiagnosed as cellulitis
• Chronic phase: Hard, woody, hyperpigmented skin in the gaiter area

"Champagne Bottle Leg": The fibrosis causes tapering and narrowing of the lower calf around the ankle, while the upper calf remains bulky, resembling an inverted champagne bottle or bowling pin. This is a marker of severe, long-standing chronic venous insufficiency and predicts poorer healing outcomes.

Q5: What are the components of the 4-layer bandaging system, and how does it work?

A: The 4-layer system (e.g., Profore) is the gold standard for compression in venous leg ulcers, generating 40mmHg pressure at the ankle, graduating to ~20mmHg at the calf.

Layers (from skin outward):

1. Orthopaedic wool/padding: Absorbs exudate; protects bony prominences; increases limb circumference to reduce focal pressure
2. Crepe bandage: Smooths layer 1; provides light compression
3. Class 3a elastic bandage: Provides sustained compression (high resting and working pressure)
4. Cohesive elastic bandage: Secures all layers; adds additional compression

Mechanism: Applies graduated external pressure → Narrows vein diameter → Improves valve coaptation → Reduces reflux → Enhances calf pump efficiency → Lowers ambulatory venous pressure from ~80mmHg to ~30mmHg → Allows ulcer healing

Application: 50% overlap spiral from base of toes to below knee; left on for 1 week (or until strike-through/slippage).

Q6: When is compression contraindicated?

A: Absolute contraindications:

• ABPI less than 0.5: Critical limb ischaemia—compression will precipitate gangrene
• Untreated septic phlebitis: Risk of septic emboli
• Acute DVT (first 2 weeks): Wait until anticoagulated and acute inflammation settled

Relative contraindications:

• ABPI 0.5-0.79: Use reduced compression (20mmHg) with caution, or refer vascular first
• Decompensated heart failure: Risk of pulmonary edema; optimize cardiac status first
• Severe peripheral neuropathy: Risk of undetected pressure injury; close monitoring
• Known allergy to bandage components: Use hypoallergenic alternatives

Always assess ABPI before compression.

Q7: How would you manage a venous leg ulcer that has not healed after 6 months of compression?

A: Non-healing (refractory) venous ulcer requires systematic reassessment:

1. Review Compression Adequacy:

• Is the patient concordant? (Check bandages applied correctly; not slipping)
• Is full compression being used? (40mmHg; if mixed disease, may need arterial optimization first)

2. Reassess Vascular Status:

• Repeat ABPI (arterial disease may have progressed)
• Repeat duplex (ensure superficial reflux has been addressed; check for deep reflux/obstruction)
• Consider venous ablation if not yet done

3. Exclude Alternative/Contributing Diagnoses:

• Biopsy (edge and base): Exclude Marjolin's ulcer (SCC), vasculitis, pyoderma gangrenosum
• Bloods: FBC (anaemia, infection), CRP, HbA1c (diabetes), albumin (nutrition), autoimmune screen (ANA, ANCA, RF)
• Probe ulcer: Check for exposed bone (osteomyelitis); arrange MRI if suspected

4. Optimize Systemic Factors:

• Nutrition: Ensure adequate protein, Vitamin C, zinc; albumin > 30g/L
• Correct anaemia: Target Hb > 10g/dL
• Glycaemic control: HbA1c less than 53mmol/mol if diabetic
• Mobility/weight: Physiotherapy; weight loss if obese

5. Consider Advanced Therapies:

• Pentoxifylline 400mg TDS: Adjunctive benefit
• Skin grafting (if clean granulating base): Split-thickness or pinch grafts
• Negative pressure wound therapy: If large/complex

6. Multidisciplinary Referral:

• Specialist wound clinic, dermatology, vascular surgery for complex cases

Q8: What is Marjolin's ulcer, and how do you diagnose it?

A: Marjolin's ulcer is a squamous cell carcinoma arising in an area of chronic inflammation or scarring, including chronic leg ulcers. It occurs in approximately 0.5-2% of chronic leg ulcers, with risk increasing with ulcer duration (especially > 10 years).

Clinical Features Suggesting Malignancy:

• Raised, rolled, or everted edges
• Rapid growth or change in character
• Bleeding or nodularity
• Failure to heal despite optimal treatment for > 3 months

Diagnosis:

• Biopsy (edge and base): 4-6mm punch or excisional biopsy
• Histology: Atypical keratinocytes with invasion into dermis/deeper structures

Management:

• Staging: CT chest/abdomen/pelvis (nodal/distant metastases)
• Treatment: Wide local excision with 1-2cm margins ± skin graft/flap; consider adjuvant radiotherapy if nodal involvement
• Prognosis: 5-year survival ~50-80% depending on stage; aggressive behavior (higher metastatic potential than primary cutaneous SCC)

Prevention: Biopsy any chronic ulcer > 3 months or with atypical features.

---

16. Rehabilitation & Structured Follow-Up

Phase 1: Active Ulcer Management

Week 0-2:

• Initiate compression bandaging (4-layer, changed weekly)
• Arrange venous duplex (target: within 2 weeks per EVRA)
• Baseline ABPI, bloods (FBC, HbA1c, albumin)
• Patient education: Importance of compression, elevation, concordance

Week 2-12 (Healing Phase):

• Weekly dressing changes + compression reapplication (community nurse or clinic)
• Monitor ulcer size (photograph/trace at each visit); expect ~30% size reduction by 4-6 weeks if treatment optimal
• Proceed to early venous ablation if duplex shows superficial reflux
• Add pentoxifylline 400mg TDS
• Optimize nutrition, mobility, analgesia

Week 12+ (If Not Healed):

• Reassess (see "refractory ulcer" approach above)
• Consider skin grafting if large, clean, stalled ulcer

Phase 2: Healed Ulcer (Recurrence Prevention)

At Healing:

• Celebrate success (often 3-6 months of effort!)
• Measure for compression hosiery: Class 2 (20-30mmHg) minimum; Class 3 (30-40mmHg) if tolerated; made-to-measure if unusual leg shape
• Educate: "Compression is for life, not just until healing"

First Year Post-Healing (High-Risk Period):

• Review every 3 months: Check skin integrity, compression compliance, early signs of recurrence
• Replace hosiery every 3-6 months (loses elasticity)
• Annual duplex if new varicosities develop

Long-Term:

• 6-12 monthly review if stable
• Immediate access for new skin breakdown
• Reinforce: Elevation, exercise, weight management, skin care

Multidisciplinary Team Roles

---

17. Historical Perspectives & Evolution of Practice

Ancient Descriptions

Hippocrates (460-370 BC):

• Described "fluxes of humours" pooling in the legs, causing ulceration
• Recommended bandaging with linen strips ("The disease which is called the varix is not often cured")

Celsius (25 BC - 50 AD):

• Roman physician; distinguished venous from arterial ulcers based on bleeding patterns

Early Modern Era

Richard Wiseman (1622-1676):

• English naval surgeon; described "varicous ulcers" in detail
• Advocated "laced stockings" (early compression hosiery) for treatment

Paul Gerson Unna (1850-1929):

• German dermatologist; developed Unna's Boot (zinc paste bandage)
• Rigid bandage provides compression; still used today in some settings
• Major advance: Combined occlusion with compression

20th Century: Understanding Pathophysiology

Sir Thomas Lewis (1940s):

• Physiological studies demonstrating ambulatory venous pressure changes in CVI

Fibrin Cuff Theory (1982) - Browse & Burnand [21]:

• Proposed pericapillary fibrin deposition as mechanism of ulceration
• Influenced decades of research (though later challenged by white cell trapping hypothesis)

Modern Evidence-Based Era

1990s-2000s:

• Cochrane Reviews establish compression as evidence-based gold standard [11]
• Development of multi-layer bandaging systems (4-layer Profore, 1992)
• ESCHAR Trial (2007): Surgery reduces recurrence [33]

2010s:

• Rise of endovenous thermal ablation (EVLT, RFA) replacing open surgery
• EVRA Trial (2018): Paradigm shift to early venous ablation [5]

Current Era:

• Focus on early intervention, minimally invasive techniques, patient quality of life
• Personalized medicine: Tailoring compression, timing of ablation, advanced therapies

---

18. Future Directions & Research Frontiers

Emerging Therapies

Cellular & Regenerative Medicine:

• Stem cell therapy: Autologous bone marrow or adipose-derived stem cells to promote angiogenesis/healing (Phase II trials ongoing)
• Platelet-rich plasma (PRP): Topical application; mixed evidence; not yet standard of care

Bioengineered Skin Substitutes:

• Apligraf, Dermagraft (keratinocyte/fibroblast constructs)
• Expensive; NICE guidance suggests use only in specialist centers for refractory ulcers [24]
• Cochrane evidence: Bilayered skin grafting more effective than conventional dressings when both used with compression [40]

Advanced Wound Dressings:

• Nanocrystalline silver, honey-impregnated, protease-modulating dressings
• Lipido-Colloid Technology with Nano-OligoSaccharide Factor (TLC-NOSF): Some RCT evidence for improved healing when combined with compression [41]
• Ongoing trials; unclear if superior to simple dressings under compression [28]

Diagnostic Advances

Artificial Intelligence (AI):

• Machine learning algorithms to predict healing trajectory from ulcer photographs
• AI-assisted duplex interpretation

Biomarkers:

• Serum/tissue biomarkers (MMPs, inflammatory cytokines) to stratify non-healers early

Compression Technology

Smart Compression:

• Pressure-sensing bandages providing real-time feedback on sub-bandage pressure
• Adjustable pneumatic systems tailored to individual ambulatory pressures
• Novel multicomponent systems (e.g., UrgoK1) achieving high working/moderate resting pressure in single bandage; demonstrated 35% complete healing at 6 weeks with high patient adherence [36]

Patient-Friendly Devices:

• Velcro wrap systems (e.g., CircAid) improving compliance in elderly/arthritic patients
• Single-use, disposable compression systems

Health Economics & Service Delivery

Telemedicine:

• Remote wound assessment via smartphone images; reduce clinic visits
• AI-guided decision support for community nurses

Cost-Effectiveness Research:

• EVRA demonstrated early ablation is cost-effective (faster healing = fewer nurse visits) [5]
• Economic models guiding service redesign (nurse-led clinics, early duplex pathways)

---

References

[1] Nelzen O. Prevalence of venous leg ulcer: the importance of the data collection method. Phlebolymphology. 2008;15(4):143-150.

[2] Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology. 2001;52 Suppl 1:S5-15. doi:10.1177/0003319701052001S02

[3] Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):333-346. doi:10.1161/CIRCULATIONAHA.113.006898

[4] Coleridge Smith PD. Leg ulcer treatment. J Vasc Surg. 2009;49(3):804-808. doi:10.1016/j.jvs.2008.11.066

[5] Gohel MS, Heatley F, Liu X, et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med. 2018;378(22):2105-2114. doi:10.1056/NEJMoa1801214

[6] Gohel MS, Taylor M, Earnshaw JJ, et al. Risk factors for delayed healing and recurrence of chronic venous leg ulcers—an analysis of 1324 legs. Eur J Vasc Endovasc Surg. 2005;29(1):74-77. doi:10.1016/j.ejvs.2004.10.002

[7] Guest JF, Ayoub N, McIlwraith T, et al. Health economic burden that wounds impose on the National Health Service in the UK. BMJ Open. 2015;5(12):e009283. doi:10.1136/bmjopen-2015-009283

[8] Nicolaides AN, Allegra C, Bergan J, et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol. 2008;27(1):1-59.

[9] Sandri JL, Barros FS, Pontes S, et al. Diameter-reflux relationship in perforating veins of patients with varicose veins. J Vasc Surg. 1999;30(5):867-874. doi:10.1016/S0741-5214(99)70011-5

[10] Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-2909. doi:10.1161/CIR.0b013e318276fbcb

[11] O'Meara S, Cullum N, Nelson EA, Dumville JC. Compression for venous leg ulcers. Cochrane Database Syst Rev. 2012;11:CD000265. doi:10.1002/14651858.CD000265.pub3

[12] Jull AB, Arroll B, Parag V, Waters J. Pentoxifylline for treating venous leg ulcers. Cochrane Database Syst Rev. 2012;12:CD001733. doi:10.1002/14651858.CD001733.pub3

[13] Burnand KG, Clemenson G, Morland M, et al. Venous lipodermatosclerosis: treatment by fibrinolytic enhancement and elastic compression. BMJ. 1980;280(6215):7-11. doi:10.1136/bmj.280.6215.7

[14] Nelzen O, Bergqvist D, Lindhagen A. Venous and non-venous leg ulcers: clinical history and appearance in a population study. Br J Surg. 1994;81(2):182-187. doi:10.1002/bjs.1800810206

[15] Choa R, Rayatt S. Malignant change in chronic leg ulcers. BMJ. 2014;349:g4901. doi:10.1136/bmj.g4901

[16] Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med (Lond). 2004;4(5):448-453. doi:10.7861/clinmedicine.4-5-448

[17] Machet L, Couhe C, Perrinaud A, et al. A high prevalence of sensitization still persists in leg ulcer patients: a retrospective series of 106 patients tested between 2001 and 2002 and a meta-analysis of 1975-2003 data. Br J Dermatol. 2004;150(5):929-935. doi:10.1111/j.1365-2133.2004.05903.x

[18] Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. Am J Prev Med. 1988;4(2):96-101.

[19] Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Repair Regen. 2004;12(2):163-168. doi:10.1111/j.1067-1927.2004.012207.x

[20] Kahn SR, Comerota AJ, Cushman M, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130(18):1636-1661. doi:10.1161/CIR.0000000000000130

[21] Browse NL, Burnand KG. The cause of venous ulceration. Lancet. 1982;2(8292):243-245. doi:10.1016/s0140-6736(82)90325-7

[22] Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration: a new hypothesis. BMJ. 1988;296(6638):1726-1727. doi:10.1136/bmj.296.6638.1726

[23] Hafner J, Nobbe S, Partsch H, et al. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol. 2010;146(9):961-968. doi:10.1001/archdermatol.2010.201

[24] National Institute for Health and Care Excellence. Varicose veins: diagnosis and management. Clinical Guideline [CG168]. Published July 2013. Updated 2020. https://www.nice.org.uk/guidance/cg168

[25] Wounds UK. Effective antimicrobial stewardship: the role of infection in wound management. Best Practice Statement. 2020. https://www.wounds-uk.com

[26] Castronuovo JJ Jr, Adera HM, Smiell JM, Price RM. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg. 1997;26(4):629-637. doi:10.1016/S0741-5214(97)70062-4

[27] Ashby RL, Gabe R, Ali S, et al. Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (Venous leg Ulcer Study IV, VenUS IV): a randomised controlled trial. Lancet. 2014;383(9920):871-879. doi:10.1016/S0140-6736(13)62368-5

[28] Westby MJ, Dumville JC, Soares MO, Stubbs N, Norman G. Dressings and topical agents for treating venous leg ulcers. Cochrane Database Syst Rev. 2017;6:CD012583. doi:10.1002/14651858.CD012583

[29] Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98(8):1079-1087. doi:10.1002/bjs.7555

[30] Layton AM, Ibbotson SH, Davies JA, Goodfield MJ. Randomised trial of aspirin for chronic venous leg ulcers. Lancet. 1994;344(8916):164-165. doi:10.1016/s0140-6736(94)92757-0

[31] Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev. 2013;1:CD001737. doi:10.1002/14651858.CD001737.pub4

[32] Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-e173. doi:10.1093/cid/cis346

[33] Barwell JR, Davies CE, Deacon J, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet. 2004;363(9424):1854-1859. doi:10.1016/S0140-6736(04)16353-8

[34] Persoon A, Heinen MM, van der Vleuten CJ, de Rooij MJ, van de Kerkhof PC, van Achterberg T. Leg ulcers: a review of their impact on daily life. J Clin Nurs. 2004;13(3):341-354. doi:10.1046/j.1365-2702.2003.00859.x

[35] Eklöf B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248-1252. doi:10.1016/j.jvs.2004.09.027

[36] Senet P, Addala A, Léger P, et al. A new compression system for treatment of venous leg ulcers: a prospective, single-arm, clinical trial (FREEDOM). J Wound Care. 2022;31(9):734-747. doi:10.12968/jowc.2022.31.9.734

[37] Patton D, Avsar P, Sayeh A, et al. A systematic review of the impact of compression therapy on quality of life and pain among people with a venous leg ulcer. Int Wound J. 2024;21(3):e14816. doi:10.1111/iwj.14816

[38] Bontinis V, Ktenidis K, Bontinis A, et al. A systematic review network meta-analysis and meta-regression on surgical and endovenous interventions for the treatment of lower limb venous ulcer disease. J Endovasc Ther. 2025;32(3):605-615. doi:10.1177/15266028231193978

[39] Salih M, Elghazaly H, Salih S, Onida S, Davies AH. A systematic review and meta-analysis assessing the impact of pentoxifylline on the healing and recurrence of venous leg ulcers. Phlebology. 2025;40(6):379-385. doi:10.1177/02683555241309797

[40] Jones JE, Nelson EA, Al-Hity A. Skin grafting for venous leg ulcers. Cochrane Database Syst Rev. 2013;(1):CD001737. doi:10.1002/14651858.CD001737.pub4

[41] Meaume S, Truchetet F, Cambazard F, et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen. 2012;20(4):500-511. doi:10.1111/j.1524-475X.2012.00810.x

---

Last Updated: 2026-01-17 Evidence Level: High (Level I-II) Citations: 35